SLG
SYNH

Stanley-Laman Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Stanley-Laman Group’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-5,680
Closed -$260K – 235
2017
Q1 		$260K Buy
+5,680
New +$283K 0.07% 205

Other funds holding SYNH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BHG
Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Stanley-Laman Group's SYNH Position: Q2 2017 in Review

Stanley-Laman Group sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2017, closing a stake of 5,680 shares — an estimated $260K sold.

Stanley-Laman Group first reported a position in SYNH in Q1 2017 and held it in 1 quarter. The position peaked at $260K in Q1 2017. 247 funds tracked by Wall St. Rank hold SYNH as of Q2 2017.

  • Stanley-Laman Group reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2017 after selling out during the quarter.
  • Stanley-Laman Group sold 5,680 Syneos Health, Inc. Class A Common Stock shares in Q2 2017, an estimated $260K.
  • Stanley-Laman Group first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2017 and held it in 1 quarter.
  • Stanley-Laman Group's Syneos Health, Inc. Class A Common Stock position peaked at $260K in Q1 2017.
  • 247 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2017.

Based on Stanley-Laman Group's 13F filing for Q2 2017, filed 7 Aug 2017.